Page 3 - Patient Selection News Today

Liver transplant might cure liver metastases in a small subset of patients with CRC but identifying which patients could benefit most remains a challenge.

Centering discussion on the JAK inhibitor pacritinib, expert panelists review data from recent clinical trials and consider how they inform real-world use of this agent.

Two nonantibiotic strategies are moving forward as possible options for the most difficult NTM pathogens.

Patient selection and discussions surrounding side effects and expectations are key when considering prescribing lecanemab and potentially other therapies targeting brain amyloid.

Studies suggest natural language processing (NLP) is an effective tool in identifying candidates for epilepsy surgery.

High placebo response rates in lupus clinical trials are making it difficult to show treatment effectiveness.

Autologous stem cell transplant reduced the risk for relapses, compared with fingolimod and natalizumab, in a recent analysis.

The Society for Cardiovascular Angiography and Interventions releases draft guidance on the adoption of renal denervation for hypertension in anticipation of regulatory approval.

A randomized controlled trial questions the value of routine perioperative palliative care consultation in patients with cancer undergoing major curative-intent surgery.

People with type 2 diabetes and a cortisol-secreting adrenal mass had worse glycemic control compared with those with type 2 diabetes and a nonfunctioning adrenal mass.